DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+13.9%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$366M
AUM Growth
+$366M
(+9.7%)
Cap. Flow
-$2.7M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
49.41%
Holding
80
New
7
Increased
18
Reduced
15
Closed
7
Top Buys
| 1 |
Day One Biopharmaceuticals
DAWN
|
$6.05M |
| 2 |
TSVT
2seventy bio
TSVT
|
$5.02M |
| 3 |
Tandem Diabetes Care
TNDM
|
$2.7M |
| 4 |
Merus
MRUS
|
$2.66M |
| 5 |
Kura Oncology
KURA
|
$2.62M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$7.89M |
| 2 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$5.7M |
| 3 |
Biohaven
BHVN
|
$5.13M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$3.81M |
| 5 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$2.79M |
Sector Composition
| 1 | Healthcare | 82.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
SPDR S&P Biotech ETF
XBI
$5.07B
| $47M | 12.85% | 565,000 -5,000 | -0.9% | -$416K |
|
|
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $24.1M | 6.59% | 612,975 | – | – |
|
3
Stereotaxis
STXS
$261M
| $20.9M | 5.72% | 13,680,554 | – | – |
|
|
BPMC
4
DELISTED
Blueprint Medicines
BPMC
| $15.9M | 4.35% | 251,521 -9,714 | -4% | -$614K |
|
5
Revolution Medicines
RVMD
$7.1B
| $13.7M | 3.75% | 512,285 -63,500 | -11% | -$1.7M |
|
6
iShares Biotechnology ETF
IBB
$5.6B
| $13M | 3.56% | 102,500 | – | – |
|
7
Ascendis Pharma
ASND
$11.8B
| $12.1M | 3.3% | 135,212 | – | – |
|
|
MORF
8
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $11.9M | 3.24% | 206,748 +27,281 | +15% | +$1.56M |
|
9
IDEAYA Biosciences
IDYA
$2.15B
| $11.3M | 3.08% | 479,820 +11,462 | +2% | +$269K |
|
10
Cytokinetics
CYTK
$4.23B
| $10.9M | 2.97% | 332,734 +56,239 | +20% | +$1.83M |
|
11
Xenon Pharmaceuticals
XENE
$2.98B
| $10.8M | 2.95% | 280,538 -35,554 | -11% | -$1.37M |
|
|
12
Merus
MRUS
$4.98B
| $10.1M | 2.77% | 384,870 +100,872 | +36% | +$2.66M |
|
13
Syndax Pharmaceuticals
SNDX
$1.41B
| $9.44M | 2.58% | 450,873 +3,800 | +0.8% | +$79.5K |
|
|
KRTX
14
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $9.15M | 2.5% | 42,173 -36,400 | -46% | -$7.89M |
|
15
DexCom
DXCM
$29.5B
| $8.68M | 2.37% | 67,552 | – | – |
|
|
SAGE
16
DELISTED
Sage Therapeutics
SAGE
| $8.48M | 2.32% | 180,306 | – | – |
|
17
Neurocrine Biosciences
NBIX
$13.8B
| $7.04M | 1.92% | 74,615 | – | – |
|
18
AtriCure
ATRC
$1.84B
| $6.2M | 1.69% | 125,529 | – | – |
|
|
19
Day One Biopharmaceuticals
DAWN
$769M
| $6.05M | 1.66% | +507,100 | New | +$6.05M |
|
|
DICE
20
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $5.93M | 1.62% | 127,585 -60,000 | -32% | -$2.79M |
|
21
Nurix Therapeutics
NRIX
$714M
| $5.56M | 1.52% | 556,695 -10,000 | -2% | -$99.9K |
|
22
KalVista Pharmaceuticals
KALV
$678M
| $5.5M | 1.5% | 611,032 -5,000 | -0.8% | -$45K |
|
|
TSVT
23
DELISTED
2seventy bio
TSVT
| $5.02M | 1.37% | +496,416 | New | +$5.02M |
|
24
Viking Therapeutics
VKTX
$3.04B
| $4.76M | 1.3% | 293,655 -25,500 | -8% | -$413K |
|
25
Accuray
ARAY
$157M
| $4.73M | 1.29% | 1,222,358 | – | – |
|